Evidence map›Paper›PMID 10756051›Full record

ArticleJournal of virology2000

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

L Alexander, E Weiskopf, T C Greenough, N C Gaddis, M R Auerbach, M H Malim, S J O'Brien, B D Walker, J L Sullivan, R C Desrosiers

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 160 citations in OpenAlex.

  1. Trial
  2. BeyondFrontiers in genetics · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genetic defects in theJournal of ginseng research · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Finding a cure for human immunodeficiency virus-1 infection.Infectious disease clinics of North America · 2014
    Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

L AlexanderNew England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772, USA.
E Weiskopf
T C Greenough
N C Gaddis
M R Auerbach
M H Malim
S J O'Brien
B D Walker
J L Sullivan
R C Desrosiers
Harvard University · USUniversity of Massachusetts Chan Medical School · USUniversity of Pennsylvania · USMassachusetts General Hospital · USNational Cancer Institute · US

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WESTMORELAND, SUSAN V. · 1985 to 2011
$139.3M
MOLECULAR BASIS FOR STV PATHOGENICITYR37AI025328 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DESROSIERS, RONALD C · 1996 to 2005
$2.5M
MOLECULAR BASIS FOR SIV PATHOGENICITYR01AI025328 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DESROSIERS, RONALD C · 1987 to 2010
$2.0M
HIV-1-SPECIFIC T CELL CLONESR01AI028568 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1989 to 2008
$1.9M
HIV-1 SPECIFIC T CELL CLONESR37AI028568 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WALKER, BRUCE D · 1994 to 2003
$1.6M
MOUSE MODELS OF CANCER, BONE DISEASE, AND LACTATIONK26RR000168 · NCRR · OHIO STATE UNIVERSITY · PI ROSOL, THOMAS J · 2000 to 2004
$547k
EARLY EVENTS IN SIV INFECTIONR01AI038559 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DESROSIERS, RONALD C · 1995 to 1998
–
NCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NIAID NIH HHS AI25328NIAID NIH HHS AI28568NIAID NIH HHS AI38559NIAID NIH HHS R01 AI025328NIAID NIH HHS R01 AI028568NIAID NIH HHS R37 AI025328NIAID NIH HHS R37 AI028568
6 · The paper itself

Abstract

Factors accounting for long-term nonprogression may include infection with an attenuated strain of human immunodeficiency virus type 1 (HIV-1), genetic polymorphisms in the host, and virus-specific immune responses. In this study, we examined eight individuals with nonprogressing or slowly progressing HIV-1 infection, none of whom were homozygous for host-specific polymorphisms (CCR5-Delta32, CCR2-64I, and SDF-1-3'A) which have been associated with slower disease progression. HIV-1 was recovered from seven of the eight, and recovered virus was used for sequencing the full-length HIV-1 genome; full-length HIV-1 genome sequences from the eighth were determined following amplification of viral sequences directly from peripheral blood mononuclear cells (PBMC). Longitudinal studies of one individual with HIV-1 that consistently exhibited a slow/low growth phenotype revealed a single amino acid deletion in a conserved region of the gp41 transmembrane protein that was not seen in any of 131 envelope sequences in the Los Alamos HIV-1 sequence database. Genetic analysis also revealed that five of the eight individuals harbored HIV-1 with unusual 1- or 2-amino-acid deletions in the Gag sequence compared to subgroup B Gag consensus sequences. These deletions in Gag have either never been observed previously or are extremely rare in the database. Three individuals had deletions in Nef, and one had a 4-amino-acid insertion in Vpu. The unusual polymorphisms in Gag, Env, and Nef described here were also found in stored PBMC samples taken 3 to 11 years prior to, or in one case 4 years subsequent to, the time of sampling for the original sequencing. In all, seven of the eight individuals exhibited one or more unusual polymorphisms; a total of 13 unusual polymorphisms were documented in these seven individuals. These polymorphisms may have been present from the time of initial infection or may have appeared in response to immune surveillance or other selective pressures. Our results indicate that unusual, difficult-to-revert polymorphisms in HIV-1 can be found associated with slow progression or nonprogression in a majority of such cases.

Indexed as

Polymorphism, GeneticReceptors, ChemokineAmino Acid SequenceAnimalsCells, CulturedChemokine CXCL12Chemokines, CXCDisease Progressiongag Gene Products, Human Immunodeficiency VirusGene Products, gagGene Products, nefGene Products, vprGenotypeHaplotypesHIV-1HIV InfectionsCCR2 protein, humanChemokine CXCL12Chemokines, CXCCXCL12 protein, humangag Gene Products, Human Immunodeficiency VirusGene Products, gagGene Products, nefGene Products, vprHLA Antigensnef Gene Products, Human Immunodeficiency Virusp6 gag protein, Human immunodeficiency virus 1Receptors, CCR2Receptors, CCR5Receptors, ChemokineReceptors, Cytokinevpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID10756051
PMCPMC111953
OpenAlexW2143977260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.